Is Obeda Available in India? Launch Details Explained (2026)
Obeda - Dr. Reddy's generic semaglutide - launched in India in March 2026. Here is everything you need to know about availability, where to buy it, and what the launch means for Indian patients.
For years, Indian patients who needed semaglutide had limited options. Ozempic was available as an expensive import, often costing ₹10,000 to ₹18,000 per month - well beyond the reach of most people. Wegovy was not available in India at all.
That changed on March 20, 2026.
Important: Always consult your healthcare provider before starting any medication. This article is for informational purposes only.
What Happened on March 20, 2026?
Novo Nordisk's patent on semaglutide in India expired on March 20, 2026. This was a highly anticipated date in Indian healthcare.
Patent expiry means that other pharmaceutical companies can now legally manufacture and sell their own versions of the molecule. Within days, multiple Indian pharma giants launched their generic semaglutide products.
Dr. Reddy's Laboratories was among the first with Obeda, launched on March 21, 2026.
Is Obeda Available in India Now?
Yes. Obeda is available in India as of March 2026.
You can find it at:
- Online pharmacies: PharmEasy, 1mg, Netmeds
- Major retail pharmacy chains: Apollo Pharmacy, MedPlus, and others
- Hospital pharmacies in metro cities
Availability started in major metros - Mumbai, Delhi, Bengaluru, Hyderabad, Chennai - and is expanding rapidly to Tier-2 cities.
Do You Need a Prescription?
Yes. Obeda is a Schedule H medicine in India, which means it requires a valid prescription from a registered medical practitioner. You cannot buy it over the counter.
If you do not have a prescription, you will need to consult a doctor first. Many telehealth platforms in India now offer GLP-1 consultations, so this process has become more accessible.
What Does the Obeda Launch Mean for Indian Patients?
This is genuinely significant news for people living with obesity or type 2 diabetes in India.
Before March 2026:
- Semaglutide was available only as expensive imported Ozempic
- Monthly cost: ₹10,000–₹18,000
- Supply was inconsistent and access was limited to urban, upper-middle-class patients
After March 2026:
- Obeda and other generic semaglutide brands are available at Indian pharmacies
- Monthly cost: ₹3,800–₹5,000 depending on dose and platform
- Made in India, stable supply expected
India has over 100 million people living with type 2 diabetes and an estimated 135 million with obesity. GLP-1 medications, until now, were out of reach for the vast majority of them.
The launch of Obeda - and other Indian generic semaglutide brands - is a turning point.
Are Other Semaglutide Brands Available in India?
Yes. Obeda is not the only option. Several Indian pharma companies launched generic semaglutide around the same time:
- Obeda - Dr. Reddy's Laboratories (for diabetes + weight management)
- Noveltreat - Sun Pharma (approved for chronic weight management)
- Sematrinity - Sun Pharma (approved for type 2 diabetes)
All three contain the same active molecule. Your doctor can help you determine which is available, most suitable, and at the best price for your situation.
How Long Will Supply Last?
One concern with the Ozempic and Wegovy launches globally was severe supply shortages. With India now manufacturing semaglutide domestically, supply should be more stable.
Dr. Reddy's and Sun Pharma have large-scale manufacturing capabilities. Early signs suggest domestic supply will be able to meet demand, though in the immediate weeks after launch, some pharmacies in smaller cities may have limited stock.
How to Get Started on Obeda
- Consult a doctor - get a formal prescription after discussing your BMI, medical history, and goals
- Check your pharmacy - confirm Obeda availability in your area or order online with prescription
- Understand the dosing schedule - start at 0.25mg weekly for 4 weeks, then increase as directed
- Read the complete Obeda side effects guide - so you know what to expect
- Set up your support system - diet, movement, and consistency matter as much as the injection
How WeightEasy Fits In
Getting access to Obeda is step one. Making it work is step two - and that is where many people struggle on their own.
WeightEasy is a GLP-1 support platform built for Indian users starting on medicines like Obeda. It provides personalized diet guidance optimized for semaglutide, side effect tracking, progress monitoring, and habit coaching - everything that makes the difference between modest results and meaningful weight loss.
If you are starting Obeda, the right support can make a significant difference. WeightEasy helps you stay consistent, manage side effects, and achieve better results.
The Bottom Line
Obeda is available in India now. It is affordable, made by a trusted Indian pharma company, and brings the same semaglutide molecule that has changed lives globally to Indian patients at a price that makes sense.
If you have been waiting for an accessible GLP-1 option in India, the wait is over. Talk to your doctor today.
Consult your healthcare provider before starting any medication.
Sources
- Dr. Reddy's Laboratories - Obeda launch announcement, March 2026
- Economic Times Health - "Pharma Companies Rush Cheap Semaglutide Shots to India" (March 2026)
- Drugs Controller General of India (DCGI) - semaglutide patent expiry announcement, March 20, 2026
- PharmEasy product listing - Obeda 2mg pre-filled pen
- ICMR National Diabetes and Obesity prevalence data (2024–2025)
FAQ
Is Obeda available in India?
Yes. Obeda was launched in India on March 21, 2026 by Dr. Reddy's Laboratories, following the expiry of the semaglutide patent on March 20, 2026. It is available at major pharmacy chains and online platforms.
Where can I buy Obeda in India?
Obeda is available on platforms like PharmEasy and 1mg, and at major pharmacy chains across India. Availability started in metros first, with wider rollout expected across Tier-2 and Tier-3 cities soon.
Do I need a prescription for Obeda?
Yes. Obeda is a Schedule H prescription medicine in India. You need a valid prescription from a registered medical practitioner to purchase it.
What is the price of Obeda in India?
Obeda 2mg pre-filled pen (1.5ml) is priced at approximately ₹4,200, with discounts bringing it to around ₹3,780 on some platforms. This is roughly 60–70% less than imported Ozempic.
How does the semaglutide patent expiry affect Indian patients?
The patent expiry allows Indian pharmaceutical companies like Dr. Reddy's to legally manufacture and sell generic semaglutide in India. This has dramatically reduced the cost, making GLP-1 treatment accessible to far more patients.
Are there other semaglutide brands available in India besides Obeda?
Yes. Several Indian pharma companies launched generic semaglutide products simultaneously. These include Noveltreat and Sematrinity (both by Sun Pharma), among others. Obeda (Dr. Reddy's) is one of the leading options.